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Abstract
Background: A secreted peptide Pep27 initiates the cell death program in S. pneumoniae through
signal transduction. This study was undertaken to evaluate the relation between the structure and
cytotoxic activity of Pep27 and its analogues on cancer cells.
Results: Pep27anal2 characterized substituting (2R→W), (4E→W), (11S→W) and (13Q→W) in
native Pep27, exhibited greater hydrophobicity and anticancer activity than Pep27 and other
analogues. The IC50 values of Pep27anal2 were approximately 10 – 30 µM in a number of cell lines
(AML-2, HL-60, Jurkat, MCF-7 and SNU-601). Confocal microscopy showed that Pep27anal2-FITC
was localized in the plasma membrane, and then moving from the membrane to subcellular
compartments with the initiation of membrane blebbing. Flow cytometric analysis using propidium
iodide and Annexin V also revealed that Pep27anal2 induced apoptosis with minor membrane
damage. Electron microscopy revealed that Pep27 induced apoptosis in Jurkat cells. The anticancer
activity of Pep27anal2 was neither abrogated by pan-caspase inhibitor (Z-VAD-fmk) nor related to
cytochrome c release from mitochondria. The 3D solution structures of these two Pep27 peptides
revealed that both form a random coil conformation in water; however, they adopted stable α-
helical conformations in solutions.
Conclusion: The results indicate that Pep27anal2 can penetrate the plasma membrane, and then
induce apoptosis in both caspase-and cytochrome c-independent manner. The hydrophobicity of
Pep27anal2 appears to play an important role in membrane permeabilization and/or anticancer
properties. The structure-functional relationships of these peptides are also discussed. It is
proposed that Pep27anal2 is a potential candidate for anticancer therapeutic agents.
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Introduction
Newly discovered peptides are becoming increasingly
important, not only as molecular tools for the under-
standing of protein-protein interactions, but also as lead
compounds. Cationic amphipathic peptides, such as
cecropins, defensins, and mellitin, induce cell death in
prokaryotic and eukaryotic cells by increasing membrane
permeability [1]. This increased permeability may lead to
cell lysis or, alternatively, may produce subtle changes in
the membrane barrier function and promote cell death
[2]. It has also been shown that the anticancer activities of
natural and synthetic cationic peptides exhibit therapeutic
activity in murine models of human tumors [3-5].
It has been proposed that processes occurring within bac-
teria are necessary to trigger endogenous suicidal enzymes
that dissolve the cell wall during antibiotic-induced autol-
ysis. Recently, Pep27, was found to initiate the cell death
program in S. pneumoniae through signal transduction
triggered via the two-component system (VncR/S) consist-
ing of a membrane-bound histidine protein kinase (e.g.,
VncS) and a cytoplasmic effector termed a response regu-
lator (e.g., VncR) [6]. Pep27 is secreted through the Vex
ABC transporter and accumulates in the medium [6,7].
Accumulated Pep27 is then sensed by VncS, converting
this histidine protein kinase into a phosphatase that
dephosphorylates phosphorylated VncR, allowing dere-
pression of autolytic pathways and resulting in the loss of
viability and lysis of pneumococcal cells.
The present study was undertaken to identify analogues of
bacterial death signal peptide Pep27 capable of inhibiting
the growth of cancer cells, and to investigate the nature of
the relation between their biologic behaviors and their
molecular structures.
Materials and methods
Culture
OCI-AML-2 (AML-2) cell line was obtained from the
Ontario Cancer Institute (Toronto, Canada), and Jurkart
and HL-60 cell lines from the American Type Culture Col-
lection (ATCC, USA). These three cell lines were cultured
at 37°C in a 5% CO2 atmosphere using α-MEM medium
(GibcoBRL, Gland Island, NY, USA) containing 10% heat-
inactivated fetal bovine serum (FBS, Sigma, ST. Louis,
MO, USA). MCF-7 and NIH/3T3 cell lines from ATCC and
SNU-601 cell line from the Korean Cancer Cell Bank
(Seoul, Korea) were cultured under the same conditions
but using RPMI-1640 medium (GibcoBRL, Gland Island,
NY, USA) containing 10% heat-inactivated FBS. Cells
were maintained in suspension or as monolayer cultures,
and subcultured.
Peptide synthesis
Peptides were synthesized by using a solid phase method
using (based on) Fmoc (9-fluorenyl-methoxycarbonyl)-
chemistry [8]. Rink amide 4-methyl benzhydrylamine
(MBHA) resin (0.55 mmol/g) was used as the support.
Coupling of Fmoc-amino acids was performed by DCC
(dicyclohexyl-carbodiimide/HOBt (1-hydroxybenzotria-
zole). After completion of peptide chain elongation, the
protected final peptide resins were treated with the rea-
gent K. The crude peptide obtained was then washed
repeatedly with diethylether, dried in vacuum, and puri-
fied by reverse-phase (RP) HPLC (LC10A, Shimadzu,
Tokyo, Japan) on a Waters 15-m Deltapak C18 column.
The purity of the peptide was checked by analytical RP-
HPLC using an Ultrasphere C18 column (4.625 cm, Beck-
man, Miami, FL, USA). Purified peptides were hydrolyzed
with 6 N HCl at 110°C for 22 h, and then dried in vac-
uum. The residues were dissolved in 0.02 N HCl and sub-
jected to amino acid analysis (8500 A, Hitachi, Tokyo,
Japan) to determine peptide concentration. The molecu-
lar weights of the synthetic peptides were determined by
MALDI (matrix-assisted laser desorption ionization) mass
spectra, respectively (data not shown).
Cytotoxicity test
The in vitro cytotoxicity of the Pep27 analogues produced
was measured by MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide, Sigma, ST. Louis, USA]
assay, as described by [9]. IC50 values were determined
directly from semilogarithmic dose-response curves.
Experiments were carried out at least in duplicate.
Hemolytic activity
Peptide hemolytic activities were measured as described
by [10], by determining hemoglobin release by 4% sus-
pensions of fresh human erythrocytes at 414 nm. Briefly,
human erythrocyte cells were centrifuged and washed
three times with phosphate-buffered saline (PBS: 35 mM
phosphate buffer/0.15 M NaCl, pH 7.0). 100 ml of
human red blood cells suspended 8% (v/v) in PBS were
the inoculated into 96-well plates. 100 ml of the peptide
solution, Pep27 or its analogues, was then added to each
well. The plates were incubated for 1 h at 37°C, and cen-
trifuged at 150 g for 5 min. 100 ml aliquots of the super-
natant obtained were transferred to flat-bottom 96-
microtiter plates. Hemolysis was determined by measur-
ing absorbance at 414 nm with an ELISA plate reader
(Molecular Devices Emax, Sunnyvale, CA, USA). Hemoly-
sis rates of 0% or 100% were determined as the same way
with PBS and 0.1% Triton-100, respectively. Hemolysis
percent was calculated using the following equation: %
hemolysis = [(Abs414nm in the peptide solution -
Abs414nm in PBS)/(Abs414nm in 0.1% Triton-100 -
Abs414nm in PBS)] × 100.Cancer Cell International 2005, 5:21 http://www.cancerci.com/content/5/1/21
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Preparation of fluorescein isothiocyanate (FITC)-labeled 
peptide
FITC was freshly dissolved in DMSO to 10 mg/ml, and
added to 1 mg/ml of peptide in 100 mM sodium bicarbo-
nate, pH 9.3 to a final concentration of 1 mg/ml FITC.
After incubation for 4 hr in the dark at room temperature,
1 M ethanolamine was added to inactivate the residual
FITC. The solution was then left in the dark for an addi-
tional 2 hr, and chromatographed sequentially on a gel-
filtration column followed by a 120 cm Sephadex G-50
column to remove unconjugated dye. The FITC-labeled
peptide (FITC-Pep27anal2) was obtained by reverse phase
HPLC using a C18 column. Conjugation between FITC
and the peptide of interest was confirmed by SDS-PAGE
gel as intense peptide fluorescence under UV light.
Confocal microscopy
Jurkat cells grown on glass coverslips overnight were
treated with FITC-labeled Pep27anal2 at a concentration
of 5 µg/ml. The cells were washed with PBS at 30, 60 and
120 min being treated of Pep27anal2, and then fixed
using 3.7% formaldehyde for 15 min. Coverslips were
mounted on glass slides, FITC was excited using a 488-nm
laser, and images were manipulated using the manufac-
ture's software.
Determination of apoptosis and membrane integrity
Annexin V binding was assessed by flow cytometry, and
cell staining was evaluated using FITC-labeled annexin V
(green fluorescence), and propidium iodide (PI) (nega-
tive for red fluorescence) simultaneously. This test was
able to discriminate between intact cells (FITC-/PI-),
apoptotic cells (FITC+/PI-) and necrotic cells (FITC+/PI+)
(Vermes et al., 1995). Jurkat cells (105/ml) were exposed
to etoposide (100 µM), mellitin (12.5 µM) and
Pep27anal2 (12.5 µM and 62.5 µM) for 4 hr. Cells were
washed with PBS, resuspended in 400 µl of binding buffer
(10 mM Hepes/NaOH, pH 7.4, 140 mM NaCl, 2.5.mM
CaCl2), and incubated with 10 µl of annexin V-FITC
(MedSystems Diagnostics, GmbH, Australia) for 10 min
at room temperature. After incubation, cells were washed
with binding buffer and exposed to 1 µg of PI in a final
volume of 400 µl. FITC and PI fluorescences were deter-
mined using a flow cytometer (Becton Dickinson, Frank-
lin Lakes, FL, USA)
Electron microscopy
Jurkat cells were harvested and immediately fixed in phos-
phate-buffered glutaraldehyde solution (pH 7.2) for 2 hrs
and then fixed in 1% buffered osmium tetroxide for 2 hrs
at 4°C. After processing through a graded series of ethanol
and propylene oxide, the cells were embedded in Epon. A
semi-thin (1 µm) section was cut and stained with toluid-
ine blue for the ultrastructural examination. Ultra-thin
(60–90 nm) sections were also prepared from the Epon
block above using an ultramicrotome (LKB-V, Sweden),
stained with uranyl acetate and lead citrate, and examined
under a Hitachi H-7600 electron microscope (Hitachi,
Kyoto, Japan). Apoptosis detection was done by taking
photographs (×1,000) of the entire field of each ultra-thin
sectioned sample. The degree of apoptosis (apoptosis
index) was defined as the number of apoptotic cells
expressed as a percentage of the total cell count.
Preparation of cytosolic extracts and the immunoblotting 
of cytochrome c
Cytochrome c immunoblotting was performed using a
slight modification of a previously described method
[11]. Jurkat cells were collected by centrifugation at 200 g
for 5 min at 4°C. The cells were then washed twice with
ice-cold PBS, pH 7.4, and centrifuged at 200 g for 5 min.
The cell pellet obtained was then resuspended in 600 µl of
extraction buffer, containing 20 mM Hepes-KOH (pH
7.5), 10 mM KCl, 250 mM sucrose, 1 mM EGTA, 1 mM
EDTA, 1.5 mM MgCl2, 1 mM dithiothreitol and 0.1 mM
phenylmethylsulfonyl fluoride.
After incubation for 30 min on ice, the cells were homog-
enized (20 strokes), spun at 14,000 g for 15 min, superna-
tants were separated from the mitochondrial fraction, and
both were stored at -70°C, until required for gel electro-
phoresis. The mitosol fraction was obtained by adding
0.1% SDS. Fifty µg of cytosolic protein extracts and the
mitosol extracts were loaded into the lanes of an 15%
SDS-polyacrylamide gel, separated and blotted onto a
nitrocellulose membrane (Amersham, Piscataway, NJ,
USA) at 150 mA overnight in transfer buffer (20 mM Tris-
base, 150 mM glycine, 20% methanol). Non-specific
binding was blocked by incubating the membrane in 5%
non-fat milk in TBS-T (Tris-buffered saline and Tween-20;
10 mM Tris-HCl pH 8.0, 50 mM NaCl, and 0.05% Tween-
20) for 3 h at RT. The membrane was incubated in anti-
cytochrome c monoclonal antibody (7H8.2Cl2) solution
(1:2000 dilution, BD PharMingen, San Diego, CA, USA)
containing 0.5% non-fat milk in TBS-T. After overnight
incubation with agitation at 4°C, the membrane was
washed three times with 0.5% non-fat milk in TBS-T. The
secondary antibody, a horseradish peroxidase-coupled
anti-mouse antibody (Sigma, ST. Louis, MO, USA), was
incubated at a 1:1000 dilution for 2 h at RT. The mem-
brane was then washed four times (5 min) with 5% non-
fat milk in TBS-T.
NMR (nuclear magnetic resonance) spectroscopy
The peptide samples used for NMR experiments con-
tained 1.5 mM peptide in water /2, 2, 2-trifluoro-(d3)-eth-
anol (TFE) mixture (50:50; v/v) at pH 7.2, which was
prepared after lyophilizing samples in an aqueous solu-
tion. NMR spectra were recorded at 15°C on a Bruker
DRX-500 spectrometer equipped with a triple-resonanceCancer Cell International 2005, 5:21 http://www.cancerci.com/content/5/1/21
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probe and an x, y, z-shielded pulsed-field gradient coil.
Two-dimensional (2D) NMR spectra were recorded in the
phase-sensitive mode using time-proportional phase
incrementation [12] for quadrature detection in the t1
domain. The 2D experiments such as TOCSY was per-
formed using a MLEV-17 spin-lock pulse sequence with a
mixing time of 69.7 ms and 2D-NOESY with mixing time
of 300 ms. Solvent suppression during TOCSY and
NOESY experiments was achieved using a WATERGATE
pulse sequence [13] in combination with a pulsed-field
gradient pulse. All NMR spectra were acquired with 2048
complex the t2 data points and 256 increments in the t1
dimension, with 32 scans per increment. Slowly exchang-
ing amide protons were identified by lyophilization of a
fully protonated sample in 50% H2O/ 50% TFE, redisso-
lution in 50% D2O/ 50% TFE solution, and the immedi-
ate acquisition of a series of one-dimensional NOESY and
2D-NOESY spectra. 3JHNα coupling constants were meas-
ured from the 1D spectrum. NMR data were processed on
a Silicon Graphics Indigo II workstation using XWINNMR
(Bruker Instruments, Karlsruhe, Germany) software. Pro-
ton chemical shifts were expressed relative to the methyl
resonance of sodium 2, 2-dimethyl-2-silapentane-5-sul-
fonic acid (DSS), used as an internal standard.
Statistical analysis
Data are expressed as means ± SEM. One-way ANOVA and
the Student's t-test were performed using the Statistical
Package for the Social Sciences (SPSS) for Windows, ver-
sion 7.5 (SPSS, Korea). Results were considered significant
when p was <0.05.
Results
Design and synthesis of peptides
The amphipathic features of α-helical antimicrobial pep-
tides plays an important role against target cells. Further-
more, a number of parameters, including a net positive
charge, α-helicity, and overall hydrophobicity have been
shown to modulate the antibiotic activity of the α-helical
amphipathic antimicrobial peptides. Recent investiga-
tions using amphipathic α-helical model peptides have
revealed that the modulation of the hydrophilic-hydro-
phobic balance of α-helical antimicrobial peptides is a
crucial factor in the design of peptides with potent antibi-
otic activity [14]. In a preliminary experiment, we could
not find that Pep27 has anticancer activity. Therefore, we
designed Pep27 analogue peptides and evaluated their
anticancer and chemosensitizing effects. In order to eluci-
date the relationship between the hydrophobic and the
hydrophilic regions of antibiotic peptides with respect to
antibiotic activity and cytotoxicity, we designed and syn-
thesized certain Pep27 analogues, on the basis of the α-
helical wheel diagram of Pep27. In particular, Pep27
hydrophobicity was increased by substituting tryptophan.
The amino acid sequences used in the present study are
summarized in Table 1. Synthesized peptides were puri-
fied by RP-HPLC and their molecular weights were con-
firmed by MALDI-MS.
RP-HPLC has often been used to experimentally deter-
mine the quantitative hydrophobic-hydrophilic balance
of amphipathic peptides. Peptides are separated by RP-
HPLC according to their hydrophobic interactions with C-
18 of the stationary phase. Such hydrophobic interactions
can be considered comparable to the interaction between
amphipathic antimicrobial peptides and the lipid bilayer
of plasma membranes. In order to investigate the possibil-
ity of a correlation between peptide hydrophobicity and
the biological activities on cancer cells, the hydrophobic
characteristics of the peptides were investigated by com-
paring their retention times on RP-HPLC (Table 1). As
expected, all Pep27 analogues eluted later than Pep27,
and the analogue Pep27anal2 had the longest retention
time.
Anticancer activities of Pep27 and its analogues
To evaluate the anticancer activities of the Pep27 ana-
logues, different concentrations of these peptides were
administered to various cancer cell lines, and cytotoxici-
ties were then determined by MTT assay. In this study, we
used both anchorage-dependent and independent cancer
cell lines. These included AML-2 an acute myelogenous
Table 1: Amino acid sequences of Pep27 derived from S. pneumoniae and its analogue peptides, and their retention times
Peptide Amino acid sequences Remarks (substitution) RT (min)
Pep27 MRKEFHNVLSSGQLLADKRPARDYNRK (2R→W), (4E→W) 14.54
Pep27anal1 MWKWFHNVLSSWQLLADKRPARDYNRK (2R→W), (4E→W) 18.67
Pep27anal2 MWKWFHNVLSWWWLLADKRPARDYNRK (2R→W), (4E→W), (11S→W), (13Q→W) 22.50
Pep27anal3 MRKWFHNVLSSGQLLADKWPAWDYNRK (4E→W), (19R→W), (22R→W), (26R→W) 20.08
Pep27anal4 MWKEFHNVLSSGQLLADKRWARWYNRW (2R→W), (20P→W), (23D→W), (27K→W) 19.15
Pep27anal5 MWKWFHNVLSSGQLLADKWWAWWYNWW (2R→W), (4E→W), (19R→W), (20P→W), (22R→W), (23D→W), 
(26R→W), (27K→W)
19.17
RT, retention time obtained by RP-HPLCCancer Cell International 2005, 5:21 http://www.cancerci.com/content/5/1/21
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leukemia cell line, HL-60 an acute promyelocytic leuke-
mia cell line, Jurkat a T cell leukemia cell line, SNU-601 a
gastric cancer cell line and MCF-7 a breast cancer cell line.
Pep27 analogue peptides showed similar anticancer activ-
ities in five cancer cell lines tested. Of the analogues
tested, Pep27anal2 showed most anticancer activity (Fig.
1). The IC50 and IC90 values of Pep27anal2 in five cancer
cell lines tested were 10 – 28 µM and 35 – 55 µM, respec-
tively (Fig. 1 and Table 2). Since the substitution of
(2R→W) and (4E→W) to form Pep27anal1 showed less
activity than Pep27anal2, the additional substitution of
(11S→W) and (13Q→W) in Pep27anal2 was viewed as
being important for anticancer activity. On the other
hand, other Pep27 analogues substituted with more than
two tryptophans at different sites did not show more anti-
cancer activity than Pep27anal2 in 5 cell lines tested.
Moreover, of the Pep27 analogues produced, Pep27anal2
had the greatest hydrophobicity, based on its RP-HPLC
retention time (Table 1).
How does Pep27anal2 show its cytotoxic effect in cancer 
cells?
In order to determine whether or not Pep27anal2 can
cause membrane damage, an RBC hemolysis test was per-
formed (Table 3). Of the Pep27 analogues, only
Pep27anal 2 at 12.5 µM for 1 h at 37°C, hemolysed 18%
of RBCs whereas mellitin at the same concentration
induced 100% hemolysis, suggesting that Pep27anal2
may cause membrane damage like mellitin. Since the
mechanism of Pep27anal 2 peptides is believed to involve
disruption of the cell membrane, confocal microscopy
used to determine whether Pep27anal2 can enter cells and
act as a membrane toxin. Jurkat cells were treated with
Pep27anal2-FITC at a concentration of 12.5 µM for 30, 60
and 120 min. After incubation cells were fixed with 3.7%
formalin for 30 min and then observed under a confocal
microscope. Confocal microscopy showed ring-shaped
cells, suggesting that Pep27anal2-FITC is localized to the
cell membrane without disturbing its integrity, and then
moves from the membrane intracellularly with time (Fig.
2). However, Jurkat cells treated with 12.5 µM
Pep27anal2 for more than 60 min showed cell shrinkage
and membrane blebbing, suggesting apoptosis, and indi-
cating that Pep27anal2 can enter cells by an unknown
mechanism and induce apoptosis whilst maintaining
membrane integrity, within 2 hr of treatment.
Determination of apoptosis after treating with 
Pep27anal2
One of the earliest events to occur during apoptosis is the
externalization of phosphatidylserine, a phospholipid
that is normally restricted the inner leaflet of the plasma
membrane. Importantly, this precedes membrane dam-
age. Moreover, the externalization of phosphatidylserine
can be monitored using annexin V, a phosphatidylserine-
specific binding protein [15]. Another important second-
ary event during apoptosis is the loss of plasma mem-
brane integrity. Intact plasma membranes exclude certain
dyes, like PI, the most commonly used marker of mem-
brane integrity [16].
In the present study, Jurkat cells were treated with 100 µM
of etoposide, 12.5 µM of mellitin or 12.5 µM or 63 µM of
Pep27anal2 for 4 hr. Apoptosis and membrane integrity
were then determined using annexin V and propidium
iodide, respectively, as described in "Materials and meth-
ods". In Fig. 4. living cells are confined to the lower left
quadrant. Dead cells appear first in the lower right quad-
rant (apoptosis), where death was due to the externaliza-
tion of PS (detected with annexin V-FITC). The upper right
quadrant shows cell death resulting from the loss of cell
membrane integrity (PI incorporation). Fig. 3 shows that
Pep27anal2 caused a higher level of annexin V-FITC stain-
ing with a little increase of PI staining than etoposide,
whereas mellitin increased the distribution of PI staining
without an increase of annexin V-FITC staining.
Table 2: Anticancer activity of Pep27 and of its analogues in various cancer cell lines by MTT assay
Peptide IC50 (µM)
AML-2 HL-60 Jurkat SNU-601 MCF-7
P e p 2 7 > 7 0> 7 0> 7 0> 7 0> 7 0
Pep27anal1 50 53 47 37 55
Pep27anal2 29 20 23 25 <10
Pep27anal3 67 52 50 50 38
Pep27anal4 50 51 46 37 29
Pep27anal5 >70 >70 >70 >70 >70
AML-2, acute myelogenous leukemia cell line; HL-60, acute promyelocytic leukemia cell line; Jurkat, T cell leukemia cell line; SNU-601, gastric 
cancer cell line; MCF-7, breast cancer cell lineCancer Cell International 2005, 5:21 http://www.cancerci.com/content/5/1/21
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Cytotoxicity of Pep27 and of its analogues in various cancer cell lines by MTT assay Figure 1
Cytotoxicity of Pep27 and of its analogues in various cancer cell lines by MTT assay. AML-2, human acute myelog-
enous leukemia cell line; HL-60, human promyelocytic leukemia cell line; Jurkat, T-cell leukemia cell line; SNU-601, human gas-
tric adenocarcinoma cell line; MCF-7, human breast cancer cell line
Table 3: Hemolytic activity of Pep27 and its analogues
Peptide % Hemolysis
0.19 µM (µM) 0.39 µM0 . 7 8   µM 1.56 µM 3.12 µM 6.25 µM 12.5 µM
P e p 2 7 0000000
P e p 2 7 a n a l 1 0000000
P e p 2 7 a n a l 2 000000 1 8
P e p 2 7 a n a l 3 0000000
P e p 2 7 a n a l 4 0000000
P e p 2 7 a n a l 5 0000000
Mellitin* 0 0 12 30 60 86 100
*, honey bee venom, which translocates across the membrane by forming a pore.
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Confocal microscopy of Jurkat cells after treatment with FITC-labeled Pep27anal2 as a function of time Figure 2
Confocal microscopy of Jurkat cells after treatment with FITC-labeled Pep27anal2 as a function of time. After 
incubating FITC-labeled Pep27anal2 for 30, 60, and 120 min, cells were fixed with 3.7% formaldehyde and analyzed using a laser 
scanning confocal microscope. Pep27anal2 peptide expression is shown as green on the left confocal microphotograph. Cells 
morphology is shown by the phase contrast microphotograph on the right.
30 min
60 min
120 minCancer Cell International 2005, 5:21 http://www.cancerci.com/content/5/1/21
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An electron microscopic examination revealed that
Pep27anal2 induced apoptosis in Jurkat cells, as charac-
terized by condensation of the cytoplasm, cell shrinkage,
loss of plasma membrane microvilli, condensed or frag-
mented nuclei, and the formation of membrane vesicles,
as in etoposide (Fig. 4). Cells treated with Pep27anal2
Determination of apoptosis and membrane integrity by FACS Figure 3
Determination of apoptosis and membrane integrity by FACS. Cells were treated with etoposide, mellitin and Pep27 
anal2. Apoptosis and membrane integrity were determined using annexin V and propidium iodide (PI), respectively, as 
described in Materials and Methods. A, control; B, 100 µM etoposide; C, 12.5 µM mellitin; D, 12.5 µM Pep27anal2; E, 62.5 µM 
Pep27anal2. Left, dual staining for annexin V-FITC (FL1-H) and PI (FL2-H); Middle, distribution of annexin V-FITC staining in 
cell populations; Right, distribution of PI staining. Similar results were obtained in independent duplicated experiments.Cancer Cell International 2005, 5:21 http://www.cancerci.com/content/5/1/21
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increased apoptosis significantly (P  < 0.05) in a time-
dependent manner. Moreover, 62.5 µM Pep27anal2
induced more apoptosis than 100 µM of etoposide (Fig.
4).
Pep27anal2 does not induce cytochrome c release from 
mitochondria to the cytosol in Jurkat cells
Cytochrome c is a well-characterized mitochondrial pro-
tein and is involved in cellular energy metabolism. The
precursor of cytochrome c, apocytochrome c, is synthe-
sized in the cytoplasm. Upon translocation to mitochoin-
dria, cytochrome c is refolded and acquires a heme
moiety, which is required for functionality in the
mitochondrial respiration chain. The heme-bound form
of cytochrome c is called holocytochrome c, which can
activate the caspases responsible for apoptosis by interact-
ing with protease activating factors when released into the
cytosol [17]. Jurkat cells (5 × 105/ml) were treated with
Pep27anal2 at a concentration of 12.5 µM for 1 h, 2 h, and
4 h and at 62.5 µM for 4 h. After these incubations, cyto-
chrome c in the cytosol fraction, obtained by 14,000 g
centrifugation for 15 min, and in the mitosol, obtained by
adding 0.1% SDS to the mitochondrial fraction, was
determined by Western blotting. Pep27anal2 at 62.5 µM
did not induce cytochrome c release from mitochondria
into the cytosol within 4 hrs (Fig. 5).
Time-dependency on Pep27anal2 – induced apoptosis in Jukart cells Figure 4
Time-dependency on Pep27anal2 – induced apoptosis in Jukart cells. Apoptotic cells were counted among 200–400 
cells in each group. The representative electron microscopic findings show apoptosis induced by etoposide or by Pep27anal2 
after 4-hr incubation. (a) Control group. Some apoptotic cells were found. (b) Etoposide treated group. Apoptotic cells were 
more frequent than in the control group. (c) Pep27anal2 treated group. Apoptotic cells were most frequent in this group. Lead 
citrate and uranyl acetate staining. Scale bar measures 9.9 µm. Arrows indicate apoptotic cells.
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Solution structures of both Pep27 and Pep27anal2
Complete proton resonance assignments for Pep27 and
Pep27anal2 were obtained using the standard sequential
resonance assignment procedure. Once the individual
spin systems had been classified, backbone sequential res-
onance assignments were completed by dαN (i,i+1) NOE
connectivities in the 2D-NOESY spectra. Figure 6 summa-
rizes the sequential and short-range NOE connectivities
observed for Pep27 and Pep27anal2 in TFE/H2O (1v/1v).
The observations of continuous dNN(i,i+1) contacts,
together with the characteristic dαN(i,i+3) and dαβ (i,i+3)
NOEs strongly support the existence of α-helices (Fig. 6).
The amide proton temperature coefficient also supports
the hypothesis that intramolecular hydrogen bonds stabi-
lize the structures of the Pep27 and Pep27anal2 helices.
This result is further supported by the backbone amide
proton exchange data of both peptides [18], and the small
3JHNα coupling constants of Pep27anal2 (that of Pep27
could not be measured). The NMR structures of Pep27
and Pep27anal2 were calculated using the experimental
restraints derived from the 2D-NOESY spectra. A total of
50 distance geometry geometric structures served as start-
ing structures for the dynamic simulated-annealing calcu-
lations for the peptides in TFE/H2O solution. The 20
lowest-energy structures (<SA>k) of 50 simulated anneal-
ing structures were selected for detailed structural analysis.
A best-fit superposition of 20 <SA>k structures and an
energy-minimized average structure ( ) are
shown in Fig. 7. The main secondary-structural feature of
Pep27 is one α-helix spanning residues, His6 -Leu15 in
TFE/H2O (1v/1v), whereas Pep27anal2 has a more stable
α-helix spanning Trp 4-Leu15 (Fig. 7).
Discussion
In this study, we investigated the anticancer activities of
Pep27 analogues. Although Pep27 did not show
anticancer activity at concentrations greater than 70 µM,
its analogues were found to have various cytotoxicities in
a number of cancer cell lines. Of the five Pep27 analogue
peptides synthesized, Pep27anal2 showed both greatest
hydrophobicity and anticancer activity. Our results sug-
gest that substitutions of (2R→W), (4E→W), (11S→W),
and (13Q→W) in Pep27 anal2 plays an important role in
its hydrophobicity and/or anticancer activity. In
particular, the latter two substitutions contribute hydro-
phobicity or anticancer activity to Pep27anal2, by virtue
of the lower anticancer activity of Pep27anal1, containing
(2R→W) and (4E→W) substitutions. In addition, substitu-
tions with the more hydrophobic amino acid tryptophan
were not always reflected by a higher hydrophobicity or a
Western blotting of cytochrome c released from mitochondria Figure 5
Western blotting of cytochrome c released from mitochondria. Jurkat cells (5 × 105/ml) were treated with 
Pep27anal2 at 12.5 µM for 1 h, 2 h, and 4 h, and at 62.5 µM for 4 h. Mitochondria were pelleted by centrifugation, and the 
supernatants retained. As a control, mitochondria were treated with 0.1% (vol/vol) SDS, which induces cytochrome c release 
from mitochondria. Protein from each fraction was subjected to SDS/PAGE for Western blot analysis using an anti-cytochrome 
c antibody. 1, the result of analyzing 50 µg of cytosol after adding no Pep27anal2; 2, 50 µg cytosol after 12.5 µM for 1 hr; 3, 50 
µg cytosol after 12.5 µM Pep27anal2 for 2 hr; 4, 50 µg cytosol after 12.5 µM Pep27anal2 for 4 hr; 5, 50 µg cytosol after 62.5 
µM Pep27anal2 for 4 hr; 6, 50 µg mitosol after 0.1% SDS; 7, 25 µg mitosol after 0.1% SDS.
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Summary of the sequential and short-range NOEs for Pep27 and for Pep27anal 2 in TFE/water (1:1 v/v) at pH 7.2 and 15°C,  showing sequential and short-range NOE contacts Figure 6
Summary of the sequential and short-range NOEs for Pep27 and for Pep27anal 2 in TFE/water (1:1 v/v) at pH 
7.2 and 15°C, showing sequential and short-range NOE contacts. Amide proton exchange rates (■ ), backbone vicinal 
coupling constants (● ; 3JHNα < 6 Hz) are also indicated. represents a proline residue The helical region is represented as a long 
cylinder.
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greater anticancer activity. Pep27anal2 had greater hydro-
phobicity than other analogues as assessed by RP-HPLC.
A positive linear correlation was observed between apo-
protein hydrophobicity and column retention time
obtained by RP-HPLC [19]. Thus, it could be implicated
that the hydrophobicity of peptides, rather than the
A comparison of the 3D solution structures of Pep27 and Pep27anal2 Figure 7
A comparison of the 3D solution structures of Pep27 and Pep27anal2. Final simulated-annealing structures of Pep27 
and Pep27anal2. Superposition of the final 20 <SA>k structures of Pep27 and Pep27anal2 over the energy-minimized average 
structure ( ) is shown. Backbone atoms in Heavy backbone atoms are superimposed for Pep27 His6-Leu15 and 
Pep27anal 2 residues Trp4-Leu15. The helical ribbon was generated using the MOLMOL program.
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number of hydrophobic amino acids, may play an impor-
tant role in anticancer activity or membrane transport.
Since peptides cannot readily enter cells, substitution of
amino acids not interfering with activity or conjugation
with other peptides to facilitate peptide cell entry has been
tried. Certain short peptides, which are able to traverse the
cell membranes, and which have low lytic activity, can be
useful as carriers (vectors) for hydrophilic molecules. Cell
penetrating peptides include pAntp ('penetratin'), trans-
portan, MAP (KLAL), Tat (48–60) and VP22. pAntp is a
60-amino acid polypeptide with a sequence that corre-
sponds to the Drosophila antennapedia homeobox gene
[20]. Transportan is a 27 amino acid peptide containing
12 functional amino acids from the amino terminus of
the neuropeptide galanin and mastoparan at the carboxyl
terminus, which are connected by a lysine [21]. MAP
(KLAL peptide) is derived from an amphipathic model
peptide, KLALKLALKALKAAKLA-NH2 [22]. TAT protein
from human immunodeficiency virus (HIV-1), is able to
deliver biologically active proteins in vivo, and is of con-
siderable interest for protein therapeutics [23]. Recently
the HIV-1 transcription (Tat) protein transduction
domain (RKKRRQRRR) has been conjugated into various
types of amino acids or proteins [24-26]. Of the cell
penetrating peptides, MAP (KLAL) was found to have the
fastest uptake, followed by transportan, Tat(48–60), and
finally, penetratin [27]. The herpes simplex virus type 1
tegument protein VP22 has recently been shown to medi-
ate the intercellular transport of proteins, raising the pos-
sibility that it may be helpful in a setting where the global
delivery of therapeutic proteins is desired [28,29].
In the present study, confocal microscopy showed that
Pep27anal2 does not act as a membrane toxin like melli-
tin, but rather penetrates cells by an unknown mecha-
nism, and induces apoptosis as characterized by cell
shrinkage and membrane blebbing. Flow cytometry was
performed to determine if Pep27anal2 induces apoptosis
and membrane damage. Annexin V binding with the cell
surface was used as being indicative of apoptosis, in con-
junction with a dye exclusion test to establish integrity of
the cell membrane. Annexin V is a Ca2+ dependent phos-
pholipid-binding protein with high affinity for phos-
phatidylserine. However, the translocation of
phosphatidylserine to the external cell surface is not
unique to apoptosis, and also occurs during necrosis. The
difference between these two forms of cell death is that
during the initial stages of apoptosis the cell membrane
remains intact, while at the very moment that necrosis
occurs the cell membrane looses its integrity, becoming
leaky [16]. Pep27anal2 increased the annexin V-FITC
staining in Jurkat cells, whereas mellitin at the same
concentration highly increased the distribution of propid-
ium iodide staining. However, much higher concentra-
tions (62.5 µM) of Pep27anal2 further distribution of
annexin V-FITC staining, whereas propidium iodide stain-
ing increased only slightly. Cell-penetrating peptides gen-
erally have the ability to gain cell entry in an energy-
dependent manner [26]. In the present study,
Pep27anal2-induced apoptosis was not influenced by pre-
treating with the ATP depleter sodium azide (data not
shown), suggesting an energy-independent transport and/
or apoptosis mediated by Pep27anal2. In addition, elec-
tron microscopy revealed that Pep27anal2 induced the
morphological features of apoptosis in Jurkat cells, and
showed cytoplasmic condensation, cell shrinkage, loss of
plasma membrane microvilli, condensed or fragmented
nuclei, and the formation of membrane vesicles. The
highest apoptotic indices were observed for Pep27anal2,
and this was statistically significant. Cells undergoing
apoptosis in vivo showed increased cytochrome c release
to the cytosol, suggesting that mitochondria may be
involved by releasing cytochrome c [30]. When cyto-
chrome c is released into the cytosol, it activates the cas-
pases responsible for apoptosis by interacting with
protease activating factors [15]. In the cytosol, cyto-
chrome c binds to Apaf-1, which triggers the activation of
caspase-9. Caspase-9 is believed to propagate the death
signal by triggering six additional caspases (caspases-2, -3,
-6, -7, -8, and -10) but not caspases-1, -4, and -5 [31].
However, Pep27anal2 did not appear to induce cyto-
chrome c release from mitochondria within 4 h, suggest-
ing that it induces apoptosis by a cytochrome c-
independent mechanism. In addition, the anticancer
activity of Pep27anal2 was not abrogated by the pan-cas-
pase inhibitor Z-VAD-fmk (data not shown), indicating
that Pep27anal2-induced apoptosis proceeds via a cas-
pase-independent pathway. Like Pep27anal2, there have
been reported about apoptosis induced in a caspase-inde-
pendent fashion without subsequent release of cyto-
chrome c [32,33].
Based on the elucidated solution structures, Pep27 has a
short coil-helix-coil composed of residues 6–16. How-
ever, the Pep27anal2 analogue characterized by substitu-
tions at 2R→W, 4E→W, 11S→W and 13Q→W was found to
have a slightly longer more stable helical conformation
than Pep27. Our biological activity data also showed that
Pep27anal2 is more potent than Pep27. This may have
been due to an increased hydrophobic interaction by
Pep27anal2. Therefore, we suggest that helical stability
has an important role in the biological activity of Pep27.
Taken together, our results indicate that the increased
hydrophobicity of Pep27anal2 aids its penetration of the
membrane. This is followed by apoptotic induction, but
which does not involve cytochrome c release from mito-
chondria. The hydrophobicity of Pep27anal2 appears to
play an important role in its ability to penetrate the
plasma membrane and/or in its anticancer activity. Thus,Cancer Cell International 2005, 5:21 http://www.cancerci.com/content/5/1/21
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we believe that Pep27anal2 is a potential candidate for the
design of anticancer peptides.
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